Please login to the form below

Not currently logged in
Email:
Password:

Israel's IP war of words

The Israeli government's minister of industry, trade and Labour, Eli Yishai, strongly denies accusations from Teva Pharmaceuticals that he is seeking to change the Intellectual Property Law in the region

The Israeli government's minister of industry, trade and Labour, Eli Yishai, has strongly denied accusations from generic drug manufacturer Teva Pharmaceuticals that he is seeking to change the Intellectual Property Law in the region.

Teva has accused Yishai of considering giving better terms for multinational pharmaceutical companies at the expense of domestic generic drug companies.

In a press statement, Yishai said: "I have not yet made up my mind. The process has only just begun, and I reject all attempts by Teva to influence the decision through the media."

The current argument concerns the expiry of drug patents and the development, production, and marketing of generic equivalents in Israel and their export to other countries. A second issue is how much the Ministry of Health can assist Israeli companies with information about drugs made by multinational pharmaceutical companies.

Yishai met officials of the US Trade Representative (USTR) and representatives of several Israeli pharmaceutical companies in October 2007. Later, a number of delegations of multinational pharmaceutical companies visited Israel, with Merck KGaA signing a memorandum of understanding (MOU) to invest in Israel start-ups.

According to local media reports, Yishai said that changing the IP Law would encourage more multinational pharmaceutical companies to invest in Israel. But Yishai denies promised anything to the foreign companies at the meeting.

Yishai has been accused of ordering the establishment of the inter-ministerial team to review the patent law. Representatives from the Ministries of Finance, Health, Justice, and Industry will participate.

Both Teva and the Ministry of Health claim that the purpose of the committee is to change the law.

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...